Sami-Sabinsa Group Limited is a global leader in health science, specializing in nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, probiotics, and enzymes. Founded in 1988 by Dr. Muhammed Majeed, the group boasts independent research divisions working synergistically to develop products meeting global standards. With over 120 research scientists dedicated to discovering and developing standardized natural extracts, the company strives to provide alternative therapy for emerging nutritional and health needs worldwide. Committed to sustainable development, the group pioneered the contract farming model, managing close to 20,000 acres of land in India. With a substantial patent portfolio comprising over 492+ granted patents and multiple pending patent applications globally, Sami-Sabinsa Group operates seven state-of-the-art manufacturing facilities across Bengaluru, Hyderabad, and Utah (USA), all adhering to international standards. The company's global presence spans across 13 countries, including the USA, Australia, Canada, China, Germany, India, Japan, Poland, South Africa, South Korea, Brazil, UAE, and Vietnam.
There is no investment information
No recent news or press coverage available for Sami-Sabinsa Group Limited.